1,096 results
Search Results
2. Abstracts (Original Papers) Presented at the Annual Meeting of the Tamil Nadu Chapter of the Indian Society of Gastroenterology in Madurai in February 2024.
- Subjects
CYCLOOXYGENASES ,BIOMARKERS ,OSTEOPATHIC medicine ,OSTEOPOROSIS ,COLORECTAL cancer - Published
- 2024
- Full Text
- View/download PDF
3. A semantic feature enhanced YOLOv5-based network for polyp detection from colonoscopy images.
- Author
-
Wan, Jing-Jing, Zhu, Peng-Cheng, Chen, Bo-Lun, and Yu, Yong-Tao
- Subjects
ADENOMATOUS polyps ,POLYPS ,COLONOSCOPY ,ADENOMA ,DIGESTIVE organs ,COLORECTAL cancer - Abstract
Colorectal cancer (CRC) is a common digestive system tumor with high morbidity and mortality worldwide. At present, the use of computer-assisted colonoscopy technology to detect polyps is relatively mature, but it still faces some challenges, such as missed or false detection of polyps. Therefore, how to improve the detection rate of polyps more accurately is the key to colonoscopy. To solve this problem, this paper proposes an improved YOLOv5-based cancer polyp detection method for colorectal cancer. The method is designed with a new structure called P-C3 incorporated into the backbone and neck network of the model to enhance the expression of features. In addition, a contextual feature augmentation module was introduced to the bottom of the backbone network to increase the receptive field for multi-scale feature information and to focus on polyp features by coordinate attention mechanism. The experimental results show that compared with some traditional target detection algorithms, the model proposed in this paper has significant advantages for the detection accuracy of polyp, especially in the recall rate, which largely solves the problem of missed detection of polyps. This study will contribute to improve the polyp/adenoma detection rate of endoscopists in the process of colonoscopy, and also has important significance for the development of clinical work. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Methodology and challenges for harmonization of nutritional data from seven historical studies.
- Author
-
Avraham, Sivan Ben, Chetrit, Angela, Agay, Nirit, Freedman, Laurence S., Saliba, Walid, Goldbourt, Uri, Keinan-Boker, Lital, Kalter-Leibovici, Ofra, Shahar, Danit R., Kimron, Lizie, and Dankner, Rachel
- Subjects
FOOD composition ,RESEARCH questions ,DATA harmonization ,COLORECTAL cancer ,ACQUISITION of data - Abstract
Background: Collection of detailed dietary data is labor intensive and expensive, harmonization of existing data sets has been proposed as an effective tool for research questions in which individual studies are underpowered. Methods: In this paper, we describe the methodology used to retrospectively harmonize nutritional data from multiple sources, based on the individual participant data of all available studies, which collected nutritional data in Israel between 1963 and 2014. This collaboration was established in order to study the association of red and processed meat with colorectal cancer. Two types of nutritional questionnaires, the Food Frequency Questionnaires (FFQ) and the 24-h dietary recall (24HR recall), and different food composition tables, were used by the participating studies. The main exposure of interest included type of meat (total meat, red meat, and poultry) and level of processing. Results: A total of 29,560 Israeli men and women were enrolled. In studies using FFQ,the weighted mean intakes of total, red, processed meat, and poultry were 95, 27, 37 and 58 gr/day and 92, 25, 10, and 66 gr/day in studies using 24HR recall, respectively.. Despite several methodological challenges, we successfully harmonized nutritional data from the different studies. Conclusions: This paper emphasizes the significance and feasibility of harmonization of previously collected nutritional data, offering an opportunity to examine associations between a range of dietary exposures and the outcome of interest, while minimizing costs and time in epidemiological studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Regulatory role of lncH19 in RAC1 alternative splicing: implication for RAC1B expression in colorectal cancer.
- Author
-
Cordaro, Aurora, Barreca, Maria Magdalena, Zichittella, Chiara, Loria, Marco, Anello, Denise, Arena, Goffredo, Sciaraffa, Nicolina, Coronnello, Claudia, Pizzolanti, Giuseppe, Alessandro, Riccardo, and Conigliaro, Alice
- Subjects
ALTERNATIVE RNA splicing ,LINCRNA ,RNA splicing ,RNA-binding proteins ,COLORECTAL cancer - Abstract
Aberrant alternative splicing events play a critical role in cancer biology, contributing to tumor invasion, metastasis, epithelial-mesenchymal transition, and drug resistance. Recent studies have shown that alternative splicing is a key feature for transcriptomic variations in colorectal cancer, which ranks third among malignant tumors worldwide in both incidence and mortality. Long non-coding RNAs can modulate this process by acting as trans-regulatory agents, recruiting splicing factors, or driving them to specific targeted genes. LncH19 is a lncRNA dis-regulated in several tumor types and, in colorectal cancer, it plays a critical role in tumor onset, progression, and metastasis. In this paper, we found, that in colorectal cancer cells, the long non-coding RNA H19 can bind immature RNAs and splicing factors as hnRNPM and RBFOX2. Through bioinformatic analysis, we identified 57 transcripts associated with lncH19 and containing binding sites for both splicing factors, hnRNPM, and RBFOX2. Among these transcripts, we identified the mRNA of the GTPase-RAC1, whose alternatively spliced isoform, RAC1B, has been ascribed several roles in the malignant transformation. We confirmed, in vitro, the binding of the splicing factors to both the transcripts RAC1 and lncH19. Loss and gain of expression experiments in two colorectal cancer cell lines (SW620 and HCT116) demonstrated that lncH19 is required for RAC1B expression and, through RAC1B, it induces c-Myc and Cyclin-D increase. In vivo, investigation from biopsies of colorectal cancer patients showed higher levels of all the explored genes (lncH19, RAC1B, c-Myc and Cyclin-D) concerning the healthy counterpart, thus supporting our in vitro model. In addition, we identified a positive correlation between lncH19 and RAC1B in colorectal cancer patients. Finally, we demonstrated that lncH19, as a shuttle, drives the splicing factors RBFOX2 and hnRNPM to RAC1 allowing exon retention and RAC1B expression. The data shown in this paper represent the first evidence of a new mechanism of action by which lncH19 carries out its functions as an oncogene by prompting colorectal cancer through the modulation of alternative splicing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions.
- Author
-
Yan, Lei, Shi, Jia, and Zhu, Jiazuo
- Subjects
COLORECTAL cancer ,EPIGENOMICS ,CELL death ,DRUG resistance ,CARCINOGENS ,CELL analysis ,GENETIC mutation - Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, affecting millions each year. It emerges from the colon or rectum, parts of the digestive system, and is closely linked to both genetic and environmental factors. In CRC, genetic mutations such as APC, KRAS, and TP53, along with epigenetic changes like DNA methylation and histone modifications, play crucial roles in tumor development and treatment responses. This paper delves into the complex biological underpinnings of CRC, highlighting the pivotal roles of genetic alterations, cell death pathways, and the intricate network of signaling interactions that contribute to the disease's progression. It explores the dysregulation of apoptosis, autophagy, and other cell death mechanisms, underscoring the aberrant activation of these pathways in CRC. Additionally, the paper examines how mutations in key molecular pathways, including Wnt, EGFR/MAPK, and PI3K, fuel CRC development, and how these alterations can serve as both diagnostic and prognostic markers. The dual function of autophagy in CRC, acting as a tumor suppressor or promoter depending on the context, is also scrutinized. Through a comprehensive analysis of cellular and molecular events, this research aims to deepen our understanding of CRC and pave the way for more effective diagnostics, prognostics, and therapeutic strategies. Highlights: Colorectal cancer (CRC) is one of the leading causes of death among patients. CRC has been characterized with changes at the genetic and epigenetic factors. The molecular factors can be used as diagnostic and prognostic factors in CRC. The cell death mechanisms demonstrate dysregulation in CRC. Autophagy has aberrant activation in CRC and exerts dual function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. The effects of oral nutritional supplements interventions on nutritional status in patients undergoing colorectal cancer surgery: A systematic review.
- Author
-
Qin, Xiaohong, Sun, Jiao, Liu, Meiling, Zhang, Lianjie, Yin, Qing, and Chen, Si
- Subjects
WEIGHT loss ,MEDICAL information storage & retrieval systems ,BODY mass index ,CINAHL database ,BODY weight ,ORAL drug administration ,COLORECTAL cancer ,EVALUATION of medical care ,META-analysis ,CANCER patients ,SYSTEMATIC reviews ,MEDLINE ,NUTRITIONAL status ,MEDICAL databases ,ONLINE information services ,DIETARY supplements ,GRIP strength ,SARCOPENIA - Abstract
Background: The high incidence of malnutrition in patients undergoing colorectal cancer surgery can lead to unplanned weight loss, sarcopenia and reduced grip strength to the extent that it can seriously affect the prognosis of colorectal cancer patients. Objective: This study investigated the effect of oral nutritional supplements (ONS) on the prevalence of grip strength, unplanned weight loss and sarcopenia in patients undergoing colorectal cancer surgery. Methods: We systematically searched randomized controlled studies from CINAHL, PubMed, Embase, Cochrane and Web of Science and three Chinese databases (CNKI, Wan‐Fang database, VIP database) from database creation to September 2023. The risk of bias in individual studies was assessed using the Cochrane Collaboration tool, and the certainty of evidence was assessed using the five GRADE criteria. Statistical analysis was performed using the RevMan 5.3 software, and information that could not be meta‐analysed was reviewed in the form of a literature summary. Results: Eleven papers met the inclusion criteria with a combined sample size of 1070 cases, including 532 cases in the trial group and 538 cases in the control group. Four papers reported the effect of ONS on grip strength and included very low‐quality evidence supporting no effect of ONS on grip strength. Ten studies reported the effect of ONS on body weight and body mass index (BMI) and included very low‐quality evidence supporting a positive ONS on weight and BMI changes. Meta‐analysis showed a significant reduction in weight loss (12–15 weeks) and BMI loss (12–15 weeks) in patients with colorectal cancer in the ONS group. The effect of ONS on the prevalence of sarcopenia after hospital discharge was reported in two studies, and meta‐analysis showed a significant reduction in the prevalence of postoperative sarcopenia in colorectal cancer patients in the ONS group, but the quality of evidence was low. Conclusions: This study showed that the use of ONS in patients undergoing surgery for colorectal cancer improved patient weight loss and BMI reduction and reduced the prevalence of postoperative sarcopenia but did not improve patient grip strength. The quality of evidence for inclusion in the article was low or very low, and further studies are needed to provide better evidence. Summary statement: What is already known about this topic? Some guidelines recommend the use of oral nutritional supplements in the perioperative and postoperative phases for patients with colorectal cancer.Previous studies have shown inconsistent results regarding the ability of oral nutritional supplements to improve weight and BMI and reduce the prevalence of sarcopenia in cancer patients. What this paper adds? For the first time, a systematic review was conducted using the malnutrition diagnostic criteria recommended by the Global Malnutrition Leadership Initiative consensus published in 2019, with unplanned weight loss, BMI change, prevalence of sarcopenia and grip strength as outcome indicators.Oral nutritional supplements reduce the prevalence of postoperative sarcopenia in patients with colorectal cancer but do not improve patients' grip strength. The implications of this paper: This study adds to the existing evidence for the use of oral nutritional supplements in perioperative and postoperative follow‐up periods for colorectal cancer.Nursing and other healthcare professionals should use evidence of the effectiveness of oral nutritional supplements to improve nutritional support for patients with colorectal cancer in the perioperative and postoperative periods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Subjective and objective financial toxicity among colorectal cancer patients: a systematic review.
- Author
-
Azzani, Meram, Azhar, Zahir Izuan, Ruzlin, Aimi Nadira Mat, Wee, Chen Xin, Samsudin, Ely Zarina, Al-Harazi, Sabah Mohammed, and Noman, Sarah
- Subjects
COLORECTAL cancer ,CANCER patients ,CINAHL database ,LOW-income countries ,MEDICAL care costs - Abstract
Background: Colorectal cancer (CRC) is the third most common cancer type worldwide. Colorectal cancer treatment costs vary between countries as it depends on policy factors such as treatment algorithms, availability of treatments and whether the treatment is government-funded. Hence, the objective of this systematic review is to determine the prevalence and measurements of financial toxicity (FT), including the cost of treatment, among colorectal cancer patients. Methods: Medline via PubMed platform, Science Direct, Scopus, and CINAHL databases were searched to find studies that examined CRC FT. There was no limit on the design or setting of the study. Results: Out of 819 papers identified through an online search, only 15 papers were included in this review. The majority (n = 12, 80%) were from high-income countries, and none from low-income countries. Few studies (n = 2) reported objective FT denoted by the prevalence of catastrophic health expenditure (CHE), 60% (9 out of 15) reported prevalence of subjective FT, which ranges from 7 to 80%, 40% (6 out of 15) included studies reported cost of CRC management– annual direct medical cost ranges from USD 2045 to 10,772 and indirect medical cost ranges from USD 551 to 795. Conclusions: There is a lack of consensus in defining and quantifying financial toxicity hindered the comparability of the results to yield the mean cost of managing CRC. Over and beyond that, information from some low-income countries is missing, limiting global representativeness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. DP-U-Net++: inter-layer feature fusion for colorectal gland image segmentation
- Author
-
Peng, Ziyang, Peng, Kexin, Liu, Chengdao, and Zhang, Xingzhi
- Published
- 2024
- Full Text
- View/download PDF
10. Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives.
- Author
-
Lijuan Wang, Weihua Wang, Die Hu, Yan Liang, Zhanyu Liu, Tianyu Zhong, and Xiaoling Wang
- Subjects
EXTRACELLULAR vesicles ,MACROPHAGES ,COLORECTAL cancer ,CANCER cells ,HEPATOCELLULAR carcinoma ,PANCREATIC tumors - Abstract
Extracellular vesicles (EVs) are important cell-to-cell communication mediators. This paper focuses on the regulatory role of tumor-derived EVs on macrophages. It aims to investigate the causes of tumor progression and therapeutic directions. Tumor-derived EVs can cause macrophages to shift to M1 or M2 phenotypes. This indicates they can alter the M1/M2 cell ratio and have pro-tumor and antiinflammatory effects. This paper discusses several key points: first, the factors that stimulate macrophage polarization and the cytokines released as a result; second, an overview of EVs and the methods used to isolate them; third, how EVs from various cancer cell sources, such as hepatocellular carcinoma, colorectal carcinoma, lung carcinoma, breast carcinoma, and glioblastoma cell sources carcinoma, promote tumor development by inducing M2 polarization in macrophages; and fourth, how EVs from breast carcinoma, pancreatic carcinoma, lungs carcinoma, and glioblastoma cell sources carcinoma also contribute to tumor development by promoting M2 polarization in macrophages. Modified or sourced EVs from breast, pancreatic, and colorectal cancer can repolarize M2 to M1 macrophages. This exhibits anti-tumor activities and offers novel approaches for tumor treatment. Therefore, we discovered that macrophage polarization to either M1 or M2 phenotypes can regulate tumor development. This is based on the description of altering macrophage phenotypes by vesicle contents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. A Glimpse into the Role and Effectiveness of Splenectomy for Isolated Metachronous Spleen Metastasis of Colorectal Cancer Origin: Long-Term Survivals Can Be Achieved.
- Author
-
Tivadar, Beatrice Mihaela, Dumitrascu, Traian, and Vasilescu, Catalin
- Subjects
COLORECTAL cancer ,SPLENECTOMY ,SPLEEN ,METASTASIS ,ADJUVANT chemotherapy ,SPLENIC rupture - Abstract
Background: Many papers exploring the role of resectioning metastases in colorectal cancer (CRC) have focused mainly on liver and lung sites, showing improved survival compared with non-resectional therapies. However, data about exceptional metastatic sites such as splenic metastases (SMs) are scarce. This paper aims to assess the role and effectiveness of splenectomy in the case of isolated metachronous SM of CRC origin. Methods: The patients' data were extracted after a comprehensive literature search through public databases for articles reporting patients with splenectomies for isolated metachronous SM of CRC origin. Potential predictors of survival were explored, along with demographic, diagnostic, pathology, and treatment data for each patient. Results: A total of 83 patients with splenectomies for isolated metachronous SM of CRC origin were identified. The primary CRC was at an advanced stage (Duke's C—70.3%) and on the left colon (45.5%) for most patients, while the median interval between CRC resection and SM was 24 months. The median overall survival after splenectomy was 84 months, and patients younger than 62 years presented statistically significantly worse overall survival rates than those ≥62 years old (p = 0.011). There was no significant impact on the long-term outcomes for factors including primary tumor location or adjuvant chemotherapy (p values ≥ 0.070, ns). Laparoscopic splenectomy was increasingly used in the last 20 years from 2002 (33.3% vs. 0%, p < 0.001). Conclusions: Splenectomy is the optimal treatment for patients with isolated metachronous SM of CRC, with the laparoscopic approach being increasingly used and having the potential to become a standard of care. Encouraging long-term survival rates were reported in the context of a multidisciplinary approach. Younger ages are associated with worse survival. Perioperative chemotherapy in the context of a patient diagnosed with SM of CRC origin appears to be a reasonable option, although the present study failed to show any significant impact on long-term survival. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. QNetDiff: a quantitative measurement of network rewiring.
- Author
-
Nose, Shota, Shiroma, Hirotsugu, Yamada, Takuji, and Uno, Yushi
- Subjects
LARGE intestine ,COLORECTAL cancer ,HUMAN body ,CANCER patients - Abstract
Bacteria in the human body, particularly in the large intestine, are known to be associated with various diseases. To identify disease-associated bacteria (markers), a typical method is to statistically compare the relative abundance of bacteria between healthy subjects and diseased patients. However, since bacteria do not necessarily cause diseases in isolation, it is also important to focus on the interactions and relationships among bacteria when examining their association with diseases. In fact, although there are common approaches to represent and analyze bacterial interaction relationships as networks, there are limited methods to find bacteria associated with diseases through network-driven analysis. In this paper, we focus on rewiring of the bacterial network and propose a new method for quantifying the rewiring. We then apply the proposed method to a group of colorectal cancer patients. We show that it can identify and detect bacteria that cannot be detected by conventional methods such as abundance comparison. Furthermore, the proposed method is implemented as a general-purpose tool and made available to the general public. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Colorectal image analysis for polyp diagnosis.
- Author
-
Peng-Cheng Zhu, Jing-Jing Wan, Wei Shao, Xian-Chun Meng, and Bo-Lun Chen
- Subjects
IMAGE analysis ,COLON polyps ,POLYPS ,COLORECTAL cancer ,CANCER prevention - Abstract
Colorectal polyp is an important early manifestation of colorectal cancer, which is significant for the prevention of colorectal cancer. Despite timely detection and manual intervention of colorectal polyps can reduce their chances of becoming cancerous, most existing methods ignore the uncertainties and location problems of polyps, causing a degradation in detection performance. To address these problems, in this paper, we propose a novel colorectal image analysismethod for polyp diagnosis via PAM-Net. Specifically, a parallel attention module is designed to enhance the analysis of colorectal polyp images for improving the certainties of polyps. In addition, ourmethod introduces the GWD loss to enhance the accuracy of polyp diagnosis from the perspective of polyp location. Extensive experimental results demonstrate the e [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers—A Systematic Review.
- Author
-
Ciocan, Răzvan Alexandru, Ciocan, Andra, Mihăileanu, Florin Vasile, Ursu, Cristina-Paula, Ursu, Ștefan, Bodea, Cătălin, Cordoș, Ariana-Anamaria, Chiș, Bogdan Augustin, Al Hajjar, Nadim, Dîrzu, Noemi, and Dîrzu, Dan-Sebastian
- Subjects
RECTAL cancer ,NEOADJUVANT chemotherapy ,CANCER diagnosis ,BIOMARKERS ,COLORECTAL cancer ,SURVIVAL analysis (Biometry) ,INSTRUMENTAL variables (Statistics) - Abstract
Colorectal cancer (CRC) is one of the most aggressive, heterogenous, and fatal types of human cancer for which screening, and more effective therapeutic drugs are urgently needed. Early-stage detection and treatment greatly improve the 5-year survival rate. In the era of targeted therapies for all types of cancer, a complete metabolomic profile is mandatory before neoadjuvant therapy to assign the correct drugs and check the response to the treatment given. The aim of this study is to discover specific metabolic biomarkers or a sequence of metabolomic indicators that possess precise diagnostic capabilities in predicting the efficacy of neoadjuvant therapy. After searching the keywords, a total of 108 articles were identified during a timeframe of 10 years (2013–2023). Within this set, one article was excluded due to the use of non-English language. Six scientific papers were qualified for this investigation after eliminating all duplicates, publications not referring to the subject matter, open access restriction papers, and those not applicable to humans. Biomolecular analysis found a correlation between metabolomic analysis of colorectal cancer samples and poor progression-free survival rates. Biomarkers are instrumental in predicting a patient's response to specific treatments, guiding the selection of targeted therapies, and indicating resistance to certain drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Medical image fusion based on machine learning for health diagnosis and monitoring of colorectal cancer.
- Author
-
Peng, Yifeng and Deng, Haijun
- Subjects
COMPUTER-assisted image analysis (Medicine) ,COMPUTER-aided diagnosis ,IMAGE fusion ,DIAGNOSTIC imaging ,COLORECTAL cancer - Abstract
With the rapid development of medical imaging technology and computer technology, the medical imaging artificial intelligence of computer-aided diagnosis based on machine learning has become an important part of modern medical diagnosis. With the application of medical image security technology, people realize that the difficulty of its development is the inherent defect of advanced image processing technology. This paper introduces the background of colorectal cancer diagnosis and monitoring, and then carries out academic research on the medical imaging artificial intelligence of colorectal cancer diagnosis and monitoring and machine learning, and finally summarizes it with the advanced computational intelligence system for the application of safe medical imaging.In the experimental part, this paper wants to carry out the staging preparation stage. It was concluded that the staging preparation stage of group Y was higher than that of group X and the difference was statistically significant. Then the overall accuracy rate of multimodal medical image fusion was 69.5% through pathological staging comparison. Finally, the diagnostic rate, the number of patients with effective treatment and satisfaction were analyzed. Finally, the average diagnostic rate of the new diagnosis method was 8.75% higher than that of the traditional diagnosis method. With the development of computer science and technology, the application field was expanding constantly. Computer aided diagnosis technology combining computer and medical images has become a research hotspot. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. An Analytical Study on the Utility of RGB and Multispectral Imagery with Band Selection for Automated Tumor Grading.
- Author
-
Kunhoth, Suchithra and Al-Maadeed, Somaya
- Subjects
MULTISPECTRAL imaging ,TUMOR grading ,INFRARED imaging ,IMAGE processing ,INFRARED spectra - Abstract
The implementation of tumor grading tasks with image processing and machine learning techniques has progressed immensely over the past several years. Multispectral imaging enabled us to capture the sample as a set of image bands corresponding to different wavelengths in the visible and infrared spectrums. The higher dimensional image data can be well exploited to deliver a range of discriminative features to support the tumor grading application. This paper compares the classification accuracy of RGB and multispectral images, using a case study on colorectal tumor grading with the QU-Al Ahli Dataset (dataset I). Rotation-invariant local phase quantization (LPQ) features with an SVM classifier resulted in 80% accuracy for the RGB images compared to 86% accuracy with the multispectral images in dataset I. However, the higher dimensionality elevates the processing time. We propose a band-selection strategy using mutual information between image bands. This process eliminates redundant bands and increases classification accuracy. The results show that our band-selection method provides better results than normal RGB and multispectral methods. The band-selection algorithm was also tested on another colorectal tumor dataset, the Texas University Dataset (dataset II), to further validate the results. The proposed method demonstrates an accuracy of more than 94% with 10 bands, compared to using the whole set of 16 multispectral bands. Our research emphasizes the advantages of multispectral imaging over the RGB imaging approach and proposes a band-selection method to address the higher computational demands of multispectral imaging. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Research progress on the correlation between intestinal flora and colorectal cancer.
- Author
-
Xinyu Wang, Qian Zhang, Rongxuan Xu, Xiaofeng Li, and Zhijun Hong
- Subjects
COLORECTAL cancer ,HUMAN body ,MEDICAL screening ,BOTANY ,MICROBIAL ecology - Abstract
Colorectal cancer (CRC) is one of themost common gastrointestinalmalignancies in the world. With the rapid pace of life and changes in diet structure, the incidence and mortality of CRC increase year by year posing a serious threat to human health. As the most complex and largest microecosystem in the human body, intestinal microecology is closely related to CRC. It is an important factor that affects and participates in the occurrence and development of CRC. Advances in nextgeneration sequencing technology and metagenomics have provided new insights into the ecology of gut microbes. It also helps to link intestinal flora with CRC, and the relationship between intestinal flora and CRC can be continuously understood from different levels. This paper summarizes the relationship between intestinal flora and CRC and its potential role in the diagnosis of CRC providing evidence for early screening and treatment of CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions.
- Author
-
Xu Song, Jun Li, Jiang Zhu, Yun-Fei Kong, Yu-Hang Zhou, Zi-Kun Wang, and Jin Zhang
- Subjects
LYMPH node cancer ,LYMPHATIC metastasis ,COLORECTAL cancer ,LYMPH node surgery ,LYMPHADENECTOMY ,TRACHELECTOMY - Abstract
With the improvement of national health awareness and the popularization of a series of screening methods, the number of patients with early colorectal cancer is gradually increasing, and accurate prediction of lymph node metastasis of T1 colorectal cancer is the key to determining the optimal therapeutic solutions. Whether patients with T1 colorectal cancer undergoing endoscopic resection require additional surgery and regional lymph node dissection is inconclusive in current guidelines. However, we can be sure that in early colorectal cancer without lymph node metastasis, endoscopic resection alone does not affect the prognosis, and it greatly improves the quality of life and reduces the incidence of surgical complications while preserving organ integrity. Therefore, it is vital to discriminate patients without lymph node metastasis in T1 colorectal cancer, and this requires accurate predictors. This paper briefly explains the significance and shortcomings of traditional pathological factors, then extends and states the new pathological factors, clinical test factors, molecular biomarkers, and the risk assessment models of lymph node metastasis based on artificial intelligence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Ginsenosides: an immunomodulator for the treatment of colorectal cancer.
- Author
-
Jianan Qian, Yanyu Jiang, and Hongyi Hu
- Subjects
GINSENOSIDES ,COLORECTAL cancer ,GINSENG ,CHINESE medicine ,CANCER treatment ,TUMOR microenvironment - Abstract
Ginsenosides, the primary bioactive ingredients derived from the root of Panax ginseng, are eagerly in demand for tumor patients as a complementary and alternative drug. Ginsenosides have increasingly become a "hot topic" in recent years due to their multifunctional role in treating colorectal cancer (CRC) and regulating tumor microenvironment (TME). Emerging experimental research on ginsenosides in the treatment and immune regulation of CRC has been published, while no review sums up its specific role in the CRC microenvironment. Therefore, this paper systematically introduces how ginsenosides affect the TME, specifically by enhancing immune response, inhibiting the activation of stromal cells, and altering the hallmarks of CRC cells. In addition, we discuss their impact on the physicochemical properties of the tumor microenvironment. Furthermore, we discuss the application of ginsenosides in clinical treatment as their efficacy in enhancing tumor patient immunity and prolonging survival. The future perspectives of ginsenoside as a complementary and alternative drug of CRC are also provided. This review hopes to open up a new horizon for the cancer treatment of Traditional Chinese Medicine monomers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Immune checkpoint inhibitors in colorectal cancer: limitation and challenges.
- Author
-
Suying Yan, Wanting Wang, Zhiqiang Feng, Jun Xue, Weizheng Liang, Xueliang Wu, Zhiquan Tan, Xipeng Zhang, Shuai Zhang, Xichuan Li, and Chunze Zhang
- Subjects
IMMUNE checkpoint inhibitors ,COLORECTAL cancer ,TUMOR antigens ,CANCER patients ,ANTIGEN presentation - Abstract
Colorectal cancer exhibits a notable prevalence and propensity for metastasis, but the current therapeutic interventions for metastatic colorectal cancer have yielded suboptimal results. ICIs can decrease tumor development by preventing the tumor’s immune evasion, presenting cancer patients with a new treatment alternative. The increased use of immune checkpoint inhibitors (ICIs) in CRC has brought several issues. In particular, ICIs have demonstrated significant clinical effectiveness in patients with MSI-H CRC, whereas their efficacy is limited in MSS. Acquired resistance can still occur in patients with a positive response to ICIs. This paper describes the efficacy of ICIs currently in the clinical treatment of CRC, discusses the mechanisms by which acquired resistance occurs, primarily related to loss and impaired presentation of tumor antigens, reduced response of IFN-l and cytokine or metabolic dysregulation, and summarizes the incidence of adverse effects. We posit that the future of ICIs hinges upon the advancement of precise prediction biomarkers and the implementation of combination therapies. This study aims to elucidate the constraints associated with ICIs in CRC and foster targeted problem-solving approaches, thereby enhancing the potential benefits for more patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Anorectal Manometry in Pediatric Colorectal Surgical Care.
- Author
-
Wheeler, Justin C., Short, Scott S., and Rollins, Michael D.
- Subjects
ANAL disease diagnosis ,RECTAL diseases ,MANOMETERS ,STATISTICAL hypothesis testing ,T-test (Statistics) ,CANCER patient medical care ,PARAMETERS (Statistics) ,REFLEXES ,COLORECTAL cancer ,CHI-squared test ,DESCRIPTIVE statistics ,MAGNETIC resonance imaging ,PEDIATRICS ,MATHEMATICAL statistics ,MEDICAL records ,ACQUISITION of data ,DEFECATION ,DATA analysis software ,NONPARAMETRIC statistics - Abstract
Background: Pediatric colorectal specialists care for patients with a variety of defecation disorders. Anorectal (AR) manometry testing is a valuable tool in the diagnosis and management of these children. This paper provides a summary of AR manometry techniques and applications as well as a review of AR manometry findings in pediatric patients with severe defecation disorders referred to a pediatric colorectal center. This is the first study describing multi-year experience using a portable AR manometry device in pediatric patients. Methods: An electronic medical record review was performed (1/2018 to 12/2023) of pediatric patients with defecation disorders who had AR manometry testing. Demographics, diagnostic findings, and outcomes are described. Key Results: A total of 297 unique patients (56.9% male, n = 169) had AR manometry testing. Of these, 72% (n = 188) had dyssynergic defecation patterns, of which 67.6% (n = 127) had fecal soiling prior to treatment. Pelvic rehabilitation (PR) was administered to 35.4% (n = 105) of all patients. A total of 79.5% (n = 58) of the 73 patients that had fecal soiling at initial presentation and completed PR with physical therapy and a bowel management program were continent after therapy. AR manometry was well tolerated, with no major complications. Conclusions: AR manometry is a simple test that can help guide the management of pediatric colorectal surgical patients with defecation disorders. As a secondary finding, PR is a useful treatment for patients with dyssynergic stooling. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Endoscopic management of patients with familial adenomatous polyposis after prophylactic colectomy or restorative proctocolectomy – systematic review of the literature.
- Author
-
Gavric, Aleksandar, Sanchez, Liseth Rivero, Brunori, Angelo, Bravo, Raquel, Balaguer, Francesc, and Pellisé, Maria
- Subjects
ADENOMATOUS polyps ,PREVENTIVE medicine ,RESTORATIVE proctocolectomy ,POSTOPERATIVE care ,SURGERY ,RESEARCH funding ,CANCER relapse ,SURGICAL anastomosis ,ENDOSCOPIC surgery ,COLORECTAL cancer ,ADENOMA ,SYSTEMATIC reviews ,MEDLINE ,ODDS ratio ,ONLINE information services ,CONFIDENCE intervals ,SURVIVAL analysis (Biometry) ,ENDOSCOPY ,COLECTOMY ,DISEASE risk factors - Abstract
Patients with familial adenomatous polyposis (FAP) develop early colorectal adenomas and if left untreated, progression to cancer is an inevitable event. Prophylactic surgery does not prevent further development of cancer in the rectal remnant, rectal cuff in patients with ileal pouch anal anastomosis (IPAA) and even on the ileal mucosa of the pouch body. The aim of this review is to assess long-term rates of cancer and adenoma development in patients with FAP after prophylactic surgery and to summarise current recommendations for endoscopic management and surveillance of these patients. A systematic literature search of studies from January 1946 through to June 2023 was conducted using the PRISMA checklist. The electronic database PubMed was searched. Fifty-four papers involving 5010 patients were reviewed. Cancer rate in the rectal remnant was 8.8–16.7% in the western population and 37% in the eastern population. The cumulative risk of cancer 30 years after surgery was 24%. Mortality due to cancer in the rectal remnant is 1.1–11.1% with a 5-year survival rate of 55%. The adenoma rate after primary IPAA was 9.4–85% with a cumulative risk of 85% 20 years after surgery and a cumulative risk of 12% for advanced adenomas 10 years after surgery. Cumulative risk for adenomas after ileorectal anastomosis (IRA) was 85% after 5 and 100% after 10 years. Adenomas developed more frequently after stapled (33.9–57%) compared to hand-sewn (0–33%) anastomosis. We identified reports of 45 cancers in patients after IPAA of which 30 were in the pouch body and 15 in the rectal cuff or at the anastomosis. There was a significant incidence of cancer and adenomas in the rectal remnant and ileal pouch of FAP patients during the long-term follow-up. Regular endoscopic surveillance is recommended, not only in IRA patients, but also in pouch patients after proctocolectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. LightCF-Net: A Lightweight Long-Range Context Fusion Network for Real-Time Polyp Segmentation.
- Author
-
Ji, Zhanlin, Li, Xiaoyu, Liu, Jianuo, Chen, Rui, Liao, Qinping, Lyu, Tao, and Zhao, Li
- Subjects
POLYPS ,IMAGE segmentation ,COLORECTAL cancer ,CLINICAL medicine ,PYRAMIDS - Abstract
Automatically segmenting polyps from colonoscopy videos is crucial for developing computer-assisted diagnostic systems for colorectal cancer. Existing automatic polyp segmentation methods often struggle to fulfill the real-time demands of clinical applications due to their substantial parameter count and computational load, especially those based on Transformer architectures. To tackle these challenges, a novel lightweight long-range context fusion network, named LightCF-Net, is proposed in this paper. This network attempts to model long-range spatial dependencies while maintaining real-time performance, to better distinguish polyps from background noise and thus improve segmentation accuracy. A novel Fusion Attention Encoder (FAEncoder) is designed in the proposed network, which integrates Large Kernel Attention (LKA) and channel attention mechanisms to extract deep representational features of polyps and unearth long-range dependencies. Furthermore, a newly designed Visual Attention Mamba module (VAM) is added to the skip connections, modeling long-range context dependencies in the encoder-extracted features and reducing background noise interference through the attention mechanism. Finally, a Pyramid Split Attention module (PSA) is used in the bottleneck layer to extract richer multi-scale contextual features. The proposed method was thoroughly evaluated on four renowned polyp segmentation datasets: Kvasir-SEG, CVC-ClinicDB, BKAI-IGH, and ETIS. Experimental findings demonstrate that the proposed method delivers higher segmentation accuracy in less time, consistently outperforming the most advanced lightweight polyp segmentation networks. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Bismuthene-Coated Fiber-Optic Plasmonic Sensor: Theoretical Foundation for the Experimental Detection of Human Colorectal Cancer
- Author
-
Yadav, Neelesh Kumar and Maurya, Jitendra Bahadur
- Published
- 2024
- Full Text
- View/download PDF
25. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer
- Author
-
Yuan, Xiya, Huang, Haifu, Yu, Changhui, Tang, Zhenhao, and Li, Yaoxuan
- Published
- 2024
- Full Text
- View/download PDF
26. ColonGen: an efficient polyp segmentation system for generalization improvement using a new comprehensive dataset
- Author
-
Mozaffari, Javad, Amirkhani, Abdollah, and Shokouhi, Shahriar B.
- Published
- 2024
- Full Text
- View/download PDF
27. Cancer detection and segmentation using machine learning and deep learning techniques: a review
- Author
-
Rai, Hari Mohan
- Published
- 2024
- Full Text
- View/download PDF
28. Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms.
- Author
-
Jiaxin Sun, Ying Wei, Jia Wang, Mingxing Hou, and Liya Su
- Subjects
CHINESE medicine ,COLORECTAL cancer ,CANCER treatment ,HAND-foot syndrome ,OVERALL survival ,REGORAFENIB - Abstract
Colorectal cancer (CRC) is a significant global health burden, with high morbidity and mortality rates. It is often diagnosed at middle to advanced stage, affecting approximately 35% of patients at the time of diagnosis. Currently, chemotherapy has been used to improve patient prognosis and increase overall survival. However, chemotherapy can also have cytotoxic effects and lead to adverse reactions, such as inhibiting bone marrow hematopoiesis, causing digestive dysfunction, hand-foot syndrome, and even life-threatening conditions. In response to these adverse effects, researchers have proposed using Traditional Chinese Medicine (TCM) as an option to treat cancer. TCM research focuses on prescriptions, herbs, and components, which form essential components of the current research in Chinese medicine. The study and implementation of TCM prescriptions and herbs demonstrate its distinctive holistic approach to therapy, characterized by applying multi-component and multi-target treatment. TMC components have advantages in developing new drugs as they consist of single ingredients, require smaller medication dosages, have a precise measure of pharmacodynamic effects, and have a clear mechanism of action compared to TCM prescriptions and herbs. However, further research is still needed to determine whether TMC components can fully substitute the therapeutic efficacy of TCM prescriptions. This paper presents a comprehensive analysis of the research advancements made in TCM prescriptions, herbs, and components. The findings of this study can serve as a theoretical basis for researchers who are interested in exploring the potential of TCM for the treatment of colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer.
- Author
-
Gretschel, Julius, El Hage, Racha, Wang, Ruirui, Chen, Yifang, Pietzner, Anne, Loew, Andreas, Leineweber, Can G., Wördemann, Jonas, Rohwer, Nadine, Weylandt, Karsten H., and Schmöcker, Christoph
- Subjects
OMEGA-6 fatty acids ,IRINOTECAN ,OXYLIPINS ,COLORECTAL cancer ,CANCER treatment ,INFLAMMATION ,CANCER invasiveness - Abstract
Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, ranking as the third most malignant. The incidence of CRC has been increasing with time, and it is reported that Westernized diet and lifestyle play a significant role in its higher incidence and rapid progression. The intake of high amounts of omega-6 (n − 6) PUFAs and low levels of omega-3 (n − 3) PUFAs has an important role in chronic inflammation and cancer progression, which could be associated with the increase in CRC prevalence. Oxylipins generated from PUFAs are bioactive lipid mediators and have various functions, especially in inflammation and proliferation. Carcinogenesis is often a consequence of chronic inflammation, and evidence has shown the particular involvement of n − 6 PUFA arachidonic acid-derived oxylipins in CRC, which is further described in this review. A deeper understanding of the role and metabolism of PUFAs by their modifying enzymes, their pathways, and the corresponding oxylipins may allow us to identify new approaches to employ oxylipin-associated immunomodulation to enhance immunotherapy in cancer. This paper summarizes oxylipins identified in the context of the initiation, development, and metastasis of CRC. We further explore CRC chemo-prevention strategies that involve oxylipins as potential therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Colorectal cancer health and care quality indicators in a federated setting using the Personal Health Train.
- Author
-
Choudhury, Ananya, Janssen, Esther, Bongers, Bart C., van Meeteren, Nico L. U., Dekker, Andre, and van Soest, Johan
- Subjects
MEDICAL quality control ,COLORECTAL cancer ,PERSONAL training ,MEDICAL personnel ,CANCER treatment ,HOSPITALS ,CANCER hospitals - Abstract
Objective: Hospitals and healthcare providers should assess and compare the quality of care given to patients and based on this improve the care. In the Netherlands, hospitals provide data to national quality registries, which in return provide annual quality indicators. However, this process is time-consuming, resource intensive and risks patient privacy and confidentiality. In this paper, we presented a multicentric 'Proof of Principle' study for federated calculation of quality indicators in patients with colorectal cancer. The findings suggest that the proposed approach is highly time-efficient and consume significantly lesser resources. Materials and methods: Two quality indicators are calculated in an efficient and privacy presevering federated manner, by i) applying the Findable Accessible Interoperable and Reusable (FAIR) data principles and ii) using the Personal Health Train (PHT) infrastructure. Instead of sharing data to a centralized registry, PHT enables analysis by sending algorithms and sharing only insights from the data. Results: ETL process extracted data from the Electronic Health Record systems of the hospitals, converted them to FAIR data and hosted in RDF endpoints within each hospital. Finally, quality indicators from each center are calculated using PHT and the mean result along with the individual results plotted. Discussion and conclusion: PHT and FAIR data principles can efficiently calculate quality indicators in a privacy-preserving federated approach and the work can be scaled up both nationally and internationally. Despite this, application of the methodology was largely hampered by ELSI issues. However, the lessons learned from this study can provide other hospitals and researchers to adapt to the process easily and take effective measures in building quality of care infrastructures. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. A comparative study of supervised and unsupervised machine learning algorithms applied to human microbiome.
- Author
-
Kalluçi, E., Preni, B., Dhamo, X., Noka, E., Bardhi, S., Bani, K., Macchia, A., Bonetti, G., Dhuli, K., Donato, K., Bertelli, M., Zambrano, L. J. M., and Janaqi, S.
- Subjects
HUMAN microbiota ,MACHINE learning ,PRINCIPAL components analysis ,ADENOMA ,COLORECTAL cancer - Abstract
Backgorund. The human microbiome, consisting of diverse bacterial, fungal, protozoan and viral species, exerts a profound influence on various physiological processes and disease susceptibility. However, the complexity of microbiome data has presented significant challenges in the analysis and interpretation of these intricate datasets, leading to the development of specialized software that employs machine learning algorithms for these aims. Methods. In this paper, we analyze raw data taken from 16S rRNA gene sequencing from three studies, including stool samples from healthy control, patients with adenoma, and patients with colorectal cancer. Firstly, we use network-based methods to reduce dimensions of the dataset and consider only the most important features. In addition, we employ supervised machine learning algorithms to make prediction. Results. Results show that graph-based techniques reduces dimension from 255 up to 78 features with modularity score 0.73 based on different centrality measures. On the other hand, projection methods (non-negative matrix factorization and principal component analysis) reduce dimensions to 7 features. Furthermore, we apply supervised machine learning algorithms on the most important features obtained from centrality measures and on the ones obtained from projection methods, founding that the evaluation metrics have approximately the same scores when applying the algorithms on the entire dataset, on 78 feature and on 7 features. Conclusions. This study demonstrates the efficacy of graph-based and projection methods in the interpretation for 16S rRNA gene sequencing data. Supervised machine learning on refined features from both approaches yields comparable predictive performance, emphasizing specific microbial features-bacteroides, prevotella, fusobacterium, lysinibacillus, blautia, sphingomonas, and faecalibacterium-as key in predicting patient conditions from raw data. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma.
- Author
-
Bilić, Zdenko, Zovak, Mario, Glavčić, Goran, Mužina, Dubravka, Ibukić, Amir, Košec, Andro, Tomas, Davor, and Demirović, Alma
- Subjects
TUMOR budding ,COLORECTAL cancer ,HEMATOXYLIN & eosin staining ,OVERALL survival ,PROGNOSIS ,HEREDITARY nonpolyposis colorectal cancer - Abstract
Background/Objectives: Recently, some new morphological features of colorectal cancer have been discovered as important prognostic factors; in this paper, we study the relationship between tumor budding (TB) and tumor deposits (TDs). Methods: The retrospective cohort study included 90 patients with pathohistologically confirmed stage III CRC who were treated with radical surgical resection. All hematoxylin and eosin (H and E)-stained slides from each patient were reviewed, and histological parameters were recorded. The samples were divided into two groups with similar sizes: a group without TDs (N = 51) and a control group with TDs (N = 39). The presence and TB grade were further analyzed in these groups and compared with other clinical and histological features. Results: The prevalence of TB in the investigated cohort was unexpectedly high (94.4%). Overall, there were 23 (25.6%) Bd1, 20 (22.2%) Bd2, and 47 (52.2%) Bd3 cases. The presence of TDs was significantly associated with a higher number of TB (p < 0.001, OR 16.3) and, consequently, with a higher TB grade (p = 0.004, OR 11.04). A higher TB grade (p = 0.001, HR 2.28; 95% CI 1.93–4.76) and a growing number of TDs (p = 0.014, HR 1.52; 95% CI 1.09–2.1) were statistically significantly associated with shorter survival. Conclusions: TDs appear more often in patients with higher TB grades in stage III CRC. A higher TB grade and a growing number of TDs were statistically significantly associated with shorter overall survival. These results could give additional emphasis to the importance of TB as an adverse prognostic factor since a strong relationship with TDs has been demonstrated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. The Impact of Cancer Stem Cells in Colorectal Cancer.
- Author
-
Radu, Petru, Zurzu, Mihai, Tigora, Anca, Paic, Vlad, Bratucu, Mircea, Garofil, Dragos, Surlin, Valeriu, Munteanu, Alexandru Claudiu, Coman, Ionut Simion, Popa, Florian, Strambu, Victor, and Ramboiu, Sandu
- Subjects
CANCER stem cells ,DRUG resistance in cancer cells ,COLORECTAL cancer ,THERAPEUTICS ,DISEASE progression ,DRUG resistance ,CANCER patients ,RAS oncogenes - Abstract
Despite incessant research, colorectal cancer (CRC) is still one of the most common causes of fatality in both men and women worldwide. Over time, advancements in medical treatments have notably enhanced the survival rates of patients with colorectal cancer. Managing metastatic CRC involves a complex tradeoff between the potential benefits and adverse effects of treatment, considering factors like disease progression, treatment toxicity, drug resistance, and the overall impact on the patient's quality of life. An increasing body of evidence highlights the significance of the cancer stem cell (CSC) concept, proposing that CSCs occupy a central role in triggering cancer. CSCs have been a focal point of extensive research in a variety of cancer types, including CRC. Colorectal cancer stem cells (CCSCs) play a crucial role in tumor initiation, metastasis, and therapy resistance, making them potential treatment targets. Various methods exist for isolating CCSCs, and understanding the mechanisms of drug resistance associated with them is crucial. This paper offers an overview of the current body of research pertaining to the comprehension of CSCs in colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Evaluation of in vitro and in vivo anticancer activities of potassium koetjapate: a solubility improved formulation of koetjapic acid against human colon cancer.
- Author
-
Jafari, Seyedeh Fatemeh, Keshavarzi, Maryam, AbdulMajid, Amin MalikShah, Al-Suede, Fouad Saleih R., Asif, Muhammad, Khadeer Ahamed, Mohamed B., Sultan Khan, Md Shamsuddin, Elsir Hassan, Loiy Ahmed, Abdul Majid, Aman Shah, and Naseri, Mohsen
- Subjects
TRANSCRIPTION factors ,COLON cancer ,HEAT shock proteins ,COLORECTAL cancer ,CELLULAR signal transduction ,NOTCH genes - Abstract
Background and purpose: The previous work on koetjapic acid (KA) isolated from Sandoricum koetjape showed its efficacy towards colorectal cancer however KA has poor water solubility which poses the biggest hindrance to its efficacy. In the present paper, an attempt was made to study the anti-colon cancer efficacy of KA’s potassium salt i.e. potassium koetjapate (KKA) applying in vitro and in vivo methods. Experimental approach: KKA was produced by a semi-synthetic method. A human apoptosis proteome profiler array was applied to determine the protein targets responsible for the stimulation of apoptosis. Three doses of KKA were studied in athymic nude mice models to examine the in vivo anti-tumorigenic ability of KKA. Findings/Results: The results of this study demonstrated that KKA regulates the activities of various proteins. It downregulates the expression of several antiapoptotic proteins and negative regulators of apoptosis including HSP60, HSP90, Bcl-2, and IGF-1 in HCT 116 cells with consequent upregulation of TRAILR-1 and TRAILR2, p27, CD40, caspase 3, and caspase 8 proteins. Additionally, KKA showed an in vitro antimetastatic effect against HCT 116 cells. These results are feasibly related to the down-regulation of Notch, Wnt, hypoxia, and MAPK/JNK and MAPK/ERK signalling pathways in HCT 116 cells besides the up-regulation of a transcription factor for cell cycle (pRb-E2F) pathways. In addition, KKA revealed potent inhibition of tumor growth. Conclusion and implications: In sum, the findings indicate that KKA can be a promising candidate as a chemotherapeutic agent against colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Use of artificial intelligence for the prediction of lymph node metastases in early-stage colorectal cancer: systematic review.
- Author
-
Thompson, Nasya, Morley-Bunker, Arthur, McLauchlan, Jared, Glyn, Tamara, and Eglinton, Tim
- Subjects
LYMPHATIC metastasis ,ARTIFICIAL neural networks ,ARTIFICIAL intelligence ,CONVOLUTIONAL neural networks ,COLORECTAL cancer - Abstract
Background Risk evaluation of lymph node metastasis for early-stage (T1 and T2) colorectal cancers is critical for determining therapeutic strategies. Traditional methods of lymph node metastasis prediction have limited accuracy. This systematic review aimed to review the potential of artificial intelligence in predicting lymph node metastasis in early-stage colorectal cancers. Methods A comprehensive search was performed of papers that evaluated the potential of artificial intelligence in predicting lymph node metastasis in early-stage colorectal cancers. Studies were appraised using the Joanna Briggs Institute tools. The primary outcome was summarizing artificial intelligence models and their accuracy. Secondary outcomes included influential variables and strategies to address challenges. Results Of 3190 screened manuscripts, 11 were included, involving 8648 patients from 1996 to 2023. Due to diverse artificial intelligence models and varied metrics, no data synthesis was performed. Models included random forest algorithms, support vector machine, deep learning, artificial neural network, convolutional neural network and least absolute shrinkage and selection operator regression. Artificial intelligence models' area under the curve values ranged from 0.74 to 0.9993 (slide level) and 0.9476 to 0.9956 (single-node level), outperforming traditional clinical guidelines. Conclusion Artificial intelligence models show promise in predicting lymph node metastasis in early-stage colorectal cancers, potentially refining clinical decisions and improving outcomes. PROSPERO registration number CRD42023409094. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. 'Beyond my Control': Dealing with the Existential Uncertainty of Cancer in Online Texts.
- Author
-
Kvaale, Kaja, Lian, Olaug S., and Bondevik, Hilde
- Subjects
ATTITUDES toward illness ,OPTIMISM ,PELVIC tumors ,RESEARCH funding ,CULTURE ,UNCERTAINTY ,INTERNET ,COLORECTAL cancer ,EXPERIENCE ,COMMUNICATION ,PUBLISHING ,CANCER patient psychology ,GRIEF ,INTERPERSONAL relations ,PATIENTS' attitudes ,WRITTEN communication ,BLOGS - Abstract
In this paper, we explore how existential aspects of being diagnosed and living with cancer are shared in stories that are publicly communicated online. Through a narrative analysis of online texts and blogs, we explore how people deal with their cancer experiences, how cultural norms about illness are expressed in their stories and why they write and publish their stories online. We found that the writers described cancer diagnosis as a defining moment in their lives. They portrayed it as a crisis that was followed by unpredictability, doubt, grief and loss, fitting with the term 'existential uncertainty'. Writing and sharing their stories online, connecting with others and staying positive were ways of dealing with this uncertainty. These naturally occurring data offer insights into phenomena that are not easily accessed in a clinical setting; moreover, they provide unique insights into the cultural norms in which online illness narratives are embedded. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Color-CADx: a deep learning approach for colorectal cancer classification through triple convolutional neural networks and discrete cosine transform.
- Author
-
Sharkas, Maha and Attallah, Omneya
- Subjects
DEEP learning ,DISCRETE cosine transforms ,CONVOLUTIONAL neural networks ,MACHINE learning ,COLORECTAL cancer ,FEATURE selection - Abstract
Colorectal cancer (CRC) exhibits a significant death rate that consistently impacts human lives worldwide. Histopathological examination is the standard method for CRC diagnosis. However, it is complicated, time-consuming, and subjective. Computer-aided diagnostic (CAD) systems using digital pathology can help pathologists diagnose CRC faster and more accurately than manual histopathology examinations. Deep learning algorithms especially convolutional neural networks (CNNs) are advocated for diagnosis of CRC. Nevertheless, most previous CAD systems obtained features from one CNN, these features are of huge dimension. Also, they relied on spatial information only to achieve classification. In this paper, a CAD system is proposed called "Color-CADx" for CRC recognition. Different CNNs namely ResNet50, DenseNet201, and AlexNet are used for end-to-end classification at different training–testing ratios. Moreover, features are extracted from these CNNs and reduced using discrete cosine transform (DCT). DCT is also utilized to acquire spectral representation. Afterward, it is used to further select a reduced set of deep features. Furthermore, DCT coefficients obtained in the previous step are concatenated and the analysis of variance (ANOVA) feature selection approach is applied to choose significant features. Finally, machine learning classifiers are employed for CRC classification. Two publicly available datasets were investigated which are the NCT-CRC-HE-100 K dataset and the Kather_texture_2016_image_tiles dataset. The highest achieved accuracy reached 99.3% for the NCT-CRC-HE-100 K dataset and 96.8% for the Kather_texture_2016_image_tiles dataset. DCT and ANOVA have successfully lowered feature dimensionality thus reducing complexity. Color-CADx has demonstrated efficacy in terms of accuracy, as its performance surpasses that of the most recent advancements. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver.
- Author
-
Ros, Javier, Vaghi, Caterina, Baraibar, Iosune, Saoudi González, Nadia, Rodríguez-Castells, Marta, García, Ariadna, Alcaraz, Adriana, Salva, Francesc, Tabernero, Josep, and Elez, Elena
- Subjects
RAS oncogenes ,COLORECTAL cancer ,CETUXIMAB ,PROTEIN-tyrosine kinases ,GENE fusion ,CANCER patient care - Abstract
Kirsten rat sarcoma virus oncogene homolog (KRAS) is the most frequently mutated oncogene in human cancer. In colorectal cancer (CRC), KRAS mutations are present in more than 50% of cases, and the KRAS glycine-to-cysteine mutation at codon 12 (KRAS G12C) occurs in up to 4% of patients. This mutation is associated with short responses to standard chemotherapy and worse overall survival compared to non-G12C mutations. In recent years, several KRAS G12C inhibitors have demonstrated clinical activity, although all patients eventually progressed. The identification of negative feedback through the EGFR receptor has led to the development of KRAS inhibitors plus an anti-EGFR combination, thus boosting antitumor activity. Currently, several KRAS G12C inhibitors are under development, and results from phase I and phase II clinical trials are promising. Moreover, the phase III CodeBreaK 300 trial demonstrates the superiority of sotorasib-panitumumab over trifluridine/tipiracil, establishing a new standard of care for patients with colorectal cancer harboring KRAS G12C mutations. Other combinations such as adagrasib-cetuximab, divarasib-cetuximab, or FOLFIRI-panitumumab-sotorasib have also shown a meaningful response rate and are currently under evaluation. Nonetheless, most of these patients will eventually relapse. In this setting, liquid biopsy emerges as a critical tool to characterize the mechanisms of resistance, consisting mainly of acquired genomic alterations in the MAPK and PI3K pathways and tyrosine kinase receptor alterations, but gene fusions, histological changes, or conformational changes in the kinase have also been described. In this paper, we review the development of KRAS G12C inhibitors in colorectal cancer as well as the main mechanisms of resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Age-related trends in colorectal cancer diagnosis: focus on evaluation of prehabilitation and rehabilitation programs.
- Author
-
Ciumărnean, Lorena, Bancoș, Mădălina Daiana, Orășan, Olga-Hilda, Milaciu, Mircea Vasile, Alexescu, Teodora, Vlad, Călin-Vasile, Para, Ioana, Hirișcău, Elisabeta Ioana, and Dogaru, Gabriela
- Subjects
COLORECTAL cancer ,TREATMENT programs ,PREHABILITATION ,COLON cancer ,CANCER diagnosis ,RECTAL cancer - Abstract
The increase in the prevalence of both colon and rectal cancer in recent years poses challenges for the medical system in terms of patient management and indirectly incurs significant financial burdens. Purpose: The aim of this paper is to track the changes in the prevalance of the colon and rectal cancer at a tertiary clinic in Romania over time and to identify complementary methods to improve the prognosis and quality of life of cancer patients. Material and methods: We conducted an observational, longitudinal, population-based study, including all patients newly diagnosed with colon or rectal neoplasia within the time frame from 1 January 2013 to 1 January 2024 in a tertiary medical clinic in Romania. For each case included in the study, we gathered demographic data (age at the time of cancer diagnosis, gender, place of origin), location of the tumor, duration until surgical intervention, alternative treatment methods employed (such as radiation or chemotherapy, and immunotherapy), and the length of survival. We also assess the feasiblity of physical prehabilitation and rehabilitation programs for inpatients diagnosed with malignant neoplasms of the colon or rectum. Results: The study found significant differences in patient ages and the execution of prehabilitation and rehabilitation practices between those admitted for colon and rectal cancer during the periods 2013-2018 and 2019-2023, with a notable shift in the prevalence of colon versus rectal cancer over these periods. Conclusions: Prehabilitation and rehabilitation practices for colorectal cancer patients are underdocumented or suboptimal, with recent improvements in documentation, especially for rectal cancer due to colostomy needs, and an observed increase in patient age due to COVID-19 pandemic protocols. Additional research and the development of standardized protocols are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer.
- Author
-
Gherman, Alexandra, Bolundut, Dinu, Ecea, Radu, Balacescu, Loredana, Curcean, Sebastian, Dina, Constantin, Balacescu, Ovidiu, and Cainap, Calin
- Subjects
HEREDITARY nonpolyposis colorectal cancer ,COLORECTAL cancer ,IMMUNE checkpoint inhibitors ,METASTASIS ,MICRORNA ,GENE expression - Abstract
Currently, only a limited set of molecular traits are utilized to direct treatment for metastatic CRC (mCRC). The molecular classification of CRC depicts tumor heterogeneity based on gene expression patterns and aids in comprehending the biological characteristics of tumor formation, growth and prognosis. Additionally, it assists physicians in tailoring the therapeutic approach. Microsatellite instability (MSI-H)/deficient mismatch repair proteins (MMRd) status has become a ubiquitous biomarker in solid tumors, caused by mutations or methylation of genes and, in turn, the accumulation of mutations and antigens that subsequently induce an immune response. Immune checkpoint inhibitors (ICI) have recently received approval for the treatment of mCRC with MSI-H/MMRd status. However, certain individuals experience either initial or acquired resistance. The tumor-programmed cell death ligand 1 (PD-L1) has been linked to the ability of CRC to evade the immune system and promote its growth. Through comprehensive research conducted via the PUBMED database, the objectives of this paper were to review the molecular characteristics linked to tumor response in metastatic CRC in light of improved patients' outcomes following ICI therapies as seen in clinical trials and to identify particular microRNAs that can modulate the expression of specific oncoproteins, such as PD-L1, and disrupt the mechanisms that allow the immune system to be evaded. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Polypoid Lesion Segmentation Using YOLO-V8 Network in Wireless Video Capsule Endoscopy Images.
- Author
-
Sahafi, Ali, Koulaouzidis, Anastasios, and Lalinia, Mehrshad
- Subjects
CAPSULE endoscopy ,POLYPECTOMY ,GASTROINTESTINAL system ,SMALL intestine ,COLORECTAL cancer ,DEEP learning - Abstract
Gastrointestinal (GI) tract disorders are a significant public health issue. They are becoming more common and can cause serious health problems and high healthcare costs. Small bowel tumours (SBTs) and colorectal cancer (CRC) are both becoming more prevalent, especially among younger adults. Early detection and removal of polyps (precursors of malignancy) is essential for prevention. Wireless Capsule Endoscopy (WCE) is a procedure that utilises swallowable camera devices that capture images of the GI tract. Because WCE generates a large number of images, automated polyp segmentation is crucial. This paper reviews computer-aided approaches to polyp detection using WCE imagery and evaluates them using a dataset of labelled anomalies and findings. The study focuses on YOLO-V8, an improved deep learning model, for polyp segmentation and finds that it performs better than existing methods, achieving high precision and recall. The present study underscores the potential of automated detection systems in improving GI polyp identification. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. miRNA as a Biomarker for the Early Detection of Colorectal Cancer.
- Author
-
Coleman, David and Kuwada, Scott
- Subjects
EARLY detection of cancer ,MICRORNA ,NON-coding RNA ,BIOMARKERS ,GENE expression - Abstract
MicroRNAs (miRNAs) are short, non-coding RNA segments that can be detected in a variety of clinical samples, including serum, stool, and urine. While miRNAs were initially known for their effect on post-translational gene expression, the last decade of research has shown them to be promising biomarkers for the detection of many types of cancer. This paper explores the use of miRNA detection as a tool for colorectal cancer (CRC) screening. We discuss the current state of miRNA detection, compare it to the existing CRC screening tools, and highlight the advantages and drawbacks of this approach from a clinical and logistical perspective. Our research finds that miRNA-based tests for CRC show great potential, but that widespread clinical adoption will be conditional on future research overcoming key hurdles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. The role of fungi in the diagnosis of colorectal cancer.
- Author
-
Li, Xu-Huan, Luo, Ming-Ming, Wang, Zu-Xiu, Wang, Qi, and Xu, Bin
- Subjects
COLORECTAL cancer ,CANCER diagnosis ,FUNGI ,EARLY diagnosis ,BACTEROIDES fragilis - Abstract
Colorectal cancer (CRC) is a prevalent tumour with high morbidity rates worldwide, and its incidence among younger populations is rising. Early diagnosis of CRC can help control the associated mortality. Fungi are common microorganisms in nature. Recent studies have shown that fungi may have a similar association with tumours as bacteria do. As an increasing number of tumour-associated fungi are discovered, this provides new ideas for the diagnosis and prognosis of tumours. The relationship between fungi and colorectal tumours has also been recently identified by scientists. Therefore, this paper describes the limitations and prospects of the application of fungi in diagnosing CRC and predicting CRC prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Managing Colorectal Cancer from Ethology to Interdisciplinary Treatment: The Gains and Challenges of Modern Medicine.
- Author
-
Berbecka, Monika, Berbecki, Maciej, Gliwa, Anna Maria, Szewc, Monika, and Sitarz, Robert
- Subjects
COLORECTAL cancer ,ANIMAL behavior ,GENERAL practitioners ,GASTROINTESTINAL tumors ,MEDICAL screening ,NANOMEDICINE ,CETUXIMAB - Abstract
Colorectal cancer (CRC) is a common malignant tumor of the gastrointestinal tract, which has become a serious threat to human health worldwide. This article exhaustively reviews colorectal cancer's incidence and relevance, carcinogenesis molecular pathways, up-to-date treatment opportunities, prophylaxis, and screening program achievements, with attention paid to its regional variations and changes over time. This paper provides a concise overview of known CRC risk factors, including familial, hereditary, and environmental lifestyle-related risk factors. The authors take a closer look into CRC's molecular genetic pathways and the role of specific enzymes involved in carcinogenesis. Moreover, the role of the general practitioner and multidisciplinary approach in CRC treatment is summarized and highlighted based on recent recommendations and experience. This article gives a clear understanding and review of the gains and challenges of modern medicine towards CRC. The authors believe that understanding the current patterns of CRC and its revolution is imperative to the prospects of reducing its burden through cancer prevention and cancer-adjusted treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
- Author
-
Kikuchi, Koji, Ogawa, Masaaki, and Sasaki, Akira
- Subjects
COLON cancer ,COLORECTAL liver metastasis ,REGORAFENIB ,JAPANESE people ,LUNG tumors - Abstract
Background: Regorafenib is an oral diphenylurea multikinase inhibitor and currently approved for use following third-line therapy for metastatic colorectal cancer (CRC) patients. Only one case has previously been reported of metastatic CRC showing a complete response (CR) to regorafenib. Case presentation: A 68-year-old Japanese man underwent laparoscopy-assisted ileocecal resection and D3 lymphadenectomy due to his ascending colon cancer. Eighteen months after surgery, a laparoscopic hepatic left lateral segmentectomy was performed due to a liver tumor, and a pathological diagnosis of colorectal liver metastasis was made. Three months after the second surgery, contrast-enhanced computed tomography (CT) revealed multiple lung metastases. The patient had undergone 18 courses of the FOLFOX + bevacizumab chemotherapy regimen as their first-line therapy and 11 courses of the FOLFIRI + ramucirumab chemotherapy regimen as their second-line therapy. As their third-line therapy, the patient was administered the regorafenib chemotherapy regimen. We evaluated the chemotherapy treatment's effect on the lung tumors by CT after 3, 7, 11, and 17 courses of the regorafenib chemotherapy regimen, finding that the lung tumors had shrunk with time; thus, each tumor was considered a partial response (PR) based on the RECIST guidelines. After 21 courses of the regorafenib chemotherapy regimen, the chemotherapy was discontinued in response to the patient's wishes. Even at 1 and 3 months after the discontinuation of the chemotherapy, CT revealed that the lung tumors had shrunk, with each considered a PR. Furthermore, 9 months after the discontinuation of the chemotherapy, CT revealed scarring of the lung tumors. This was considered a CR, rather than a PR. The patient remains disease-free 18 months after the discontinuation of chemotherapy. Conclusions: In this paper, we present the second case of radiological CR with regorafenib for multiple lung metastases of ascending colon cancer. Currently, there is no consensus on a treatment strategy for patients with radiological CR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Are behavioral economics interventions effective in increasing colorectal cancer screening uptake: A systematic review of evidence and meta-analysis?
- Author
-
Ahadinezhad, Bahman, Maleki, Aisa, Akhondi, Amirali, Kazemi, Mohammadjavad, Yousefy, Sama, Rezaei, Fatemeh, and Khosravizadeh, Omid
- Subjects
BEHAVIORAL economics ,COLORECTAL cancer ,EARLY detection of cancer ,RANDOM effects model ,ODDS ratio ,COST effectiveness ,PUBLICATION bias - Abstract
Various interventions have been investigated to improve the uptake of colorectal cancer screening. In this paper, the authors have attempted to provide a pooled estimate of the effect size of the BE interventions running a systematic review based meta-analysis. In this study, all the published literatures between 2000 and 2022 have been reviewed. Searches were performed in PubMed, Scopus and Cochrane databases. The main outcome was the demanding the one of the colorectal cancer screening tests. The quality assessment was done by two people so that each person evaluated the studies separately and independently based on the individual participant data the modified Jadad scale. Pooled effect size (odds ratio) was estimated using random effects model at 95% confidence interval. Galbraith, Forrest and Funnel plots were used in data analysis. Publication bias was also investigated through Egger's test. All the analysis was done in STATA 15. From the initial 1966 records, 38 were included in the final analysis in which 72612 cases and 71493 controls have been studied. About 72% have been conducted in the USA. The heterogeneity of the studies was high based on the variation in OR (I
2 = 94.6%, heterogeneity X2 = 670.01 (d.f. = 36), p < 0.01). The random effect pooled odds ratio (POR) of behavioral economics (BE) interventions was calculated as 1.26 (95% CI: 1.26 to 1.43). The bias coefficient is noteworthy (3.15) and statistically significant (p< 0.01). According to the results of this meta-analysis, health policy and decision makers can improve the efficiency and cost effectiveness of policies to control this type of cancer by using various behavioral economics interventions. It's noteworthy that due to the impossibility of categorizing behavioral economics interventions; we could not perform by group analysis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
47. An Update on Prebiotics and on Their Health Effects.
- Author
-
Bevilacqua, Antonio, Campaniello, Daniela, Speranza, Barbara, Racioppo, Angela, Sinigaglia, Milena, and Corbo, Maria Rosaria
- Subjects
PREBIOTICS ,GUT microbiome ,FOOD industry ,INTESTINAL diseases ,NEUROLOGICAL disorders ,COLORECTAL cancer - Abstract
Prebiotic compounds were originally defined as "a nondigestible food ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, and thus improves host health"; however, a significant modulation of the definition was carried out in the consensus panel of The International Scientific Association for Probiotics and Prebiotics (ISAPP), and the last definition states that "prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit". Health effects of prebiotics compounds attracted the interest of researchers, food companies and Regulatory Agencies, as inferred by the number of articles on Scopus for the keywords "prebiotic" and "health effects", that is ca. 2000, for the period January 2021–January 2024. Therefore, the aim of this paper is to contribute to the debate on these topics by offering an overview of existing knowledge and advances in this field. A literature search was performed for the period 2012–2023 and after the selection of the most relevant items, the attention was focused on seven conditions for which at least 8–10 different studies were found, namely colorectal cancer, neurological or psychiatric conditions, intestinal diseases, obesity, diabetes, metabolic syndrome, and immune system disorders. In addition, the analysis of the most recent articles through the software VosViewer version 1.6.20 pointed out the existence of five clusters or macro-categories, namely: (i) pathologies; (ii) metabolic condvitions; (iii) structure and use in food; (iv) immunomodulation; (v) effect on gut microbiota. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Comparison between inverse-probability weighting and multiple imputation in Cox model with missing failure subtype.
- Author
-
Guo, Fuyu, Langworthy, Benjamin, Ogino, Shuji, and Wang, Molin
- Subjects
DISEASE risk factors ,PROCEDURE manuals ,MISSING data (Statistics) ,COMPETING risks ,ONCOLOGY nursing ,COLORECTAL cancer - Abstract
Identifying and distinguishing risk factors for heterogeneous disease subtypes has been of great interest. However, missingness in disease subtypes is a common problem in those data analyses. Several methods have been proposed to deal with the missing data, including complete-case analysis, inverse-probability weighting, and multiple imputation. Although extant literature has compared these methods in missing problems, none has focused on the competing risk setting. In this paper, we discuss the assumptions required when complete-case analysis, inverse-probability weighting, and multiple imputation are used to deal with the missing failure subtype problem, focusing on how to implement these methods under various realistic scenarios in competing risk settings. Besides, we compare these three methods regarding their biases, efficiency, and robustness to model misspecifications using simulation studies. Our results show that complete-case analysis can be seriously biased when the missing completely at random assumption does not hold. Inverse-probability weighting and multiple imputation estimators are valid when we correctly specify the corresponding models for missingness and for imputation, and multiple imputation typically shows higher efficiency than inverse-probability weighting. However, in real-world studies, building imputation models for the missing subtypes can be more challenging than building missingness models. In that case, inverse-probability weighting could be preferred for its easy usage. We also propose two automated model selection procedures and demonstrate their usage in a study of the association between smoking and colorectal cancer subtypes in the Nurses' Health Study and Health Professional Follow-Up Study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. A bibliometric and visualized in oral microbiota and cancer research from 2013 to 2022.
- Author
-
Gu, Zhiyu and Liu, Yunkun
- Subjects
ORAL cancer ,CANCER research ,BIBLIOMETRICS ,PORPHYROMONAS gingivalis ,COLORECTAL cancer - Abstract
Numerous studies have highlighted the implication of oral microbiota in various cancers. However, no bibliometric analysis has been conducted on the relationship between oral microbiota and cancer. This bibliometric analysis aimed to identify the research hotspots in oral microbiota and cancer research, as well as predict future research trends. The literature published relating to oral microbiota and cancer was searched from the Web of Science Core Collection database (WoSCC) from 2013 to 2022. VOSviewer or Citespace software was used to perform the bibliometric analysis, focusing on countries, institutions, authors, journals, keywords and references. A total of 1516 publications were included in the analysis. The number of publications related oral microbiota and cancer increased annually, reaching its peak in 2022 with 287 papers. The United States (456) and China (370) were the countries with the most publications and made significant contributions to the field. Sears CL and Zhou XD were the most productive authors. The high frequency of keywords revealed key topics, including cancer (colorectal cancer, oral cancer), oral microbiota (Fusobacterium nucleatum, Porphyromonas gingivalis), and inflammation (periodontal disease). The latest trend keywords were F. nucleatum, dysbiosis, prognosis, tumor microenvironment, gastric microbiota, complications and survival, suggesting a new hotspot in the field of oral microbiota and cancer. Our study provides a comprehensive analysis of oral microbiota and cancer research, revealing an increase in publications in recent years. Future research directions will continue to focus on the diversity of oral microbiota impacted by cancers and the underlying mechanism connecting them, providing new ideas for targeted therapy of tumorigenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer.
- Author
-
Franzén, Alexander Sebastian, Boulifa, Abdelhadi, Radecke, Clarissa, Stintzing, Sebastian, Raftery, Martin J., and Pecher, Gabriele
- Subjects
PROGRAMMED cell death 1 receptors ,DRUG efficacy ,IN vitro studies ,CELLULAR therapy ,ANTINEOPLASTIC agents ,APOPTOSIS ,CELL receptors ,COLORECTAL cancer ,CELL motility ,RESEARCH funding ,CELL lines ,TUMOR antigens ,IMMUNOTHERAPY ,LIGANDS (Biochemistry) ,PHARMACODYNAMICS - Abstract
Simple Summary: Colon cancer is a solid tumor that is a prominent contributor to global mortality. Immune cells genetically engineered with a chimeric antigen receptor (CAR) that can recognize cancer-specific targets is a new innovative therapy approach that has had success in treating blood cancers but is still in development for treating solid tumors such as colon cancer. Part of the reason for the added difficulty in targeting solid tumors is the tumor microenvironment that acts as a protective barrier around a solid tumor. In this research paper, we have developed a new cellular approach for the targeted treatment of colon cancer that is designed to overcome the tumor microenvironment. We tested this new CAR cell therapy against multiple solid colon cancer models, and confirmed its efficacy and functionality in finding and eliminating solid tumors. Colorectal carcinoma (CRC) presents a formidable medical challenge, demanding innovative therapeutic strategies. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising alternative to CAR T-cell therapy for cancer. A suitable tumor antigen target on CRC is carcinoembryonic antigen (CEA), given its widespread expression and role in tumorigenesis and metastasis. CEA is known to be prolifically shed from tumor cells in a soluble form, thus hindering CAR recognition of tumors and migration through the TME. We have developed a next-generation CAR construct exclusively targeting cell-associated CEA, incorporating a PD1-checkpoint inhibitor and a CCR4 chemokine receptor to enhance homing and infiltration of the CAR-NK-92 cell line through the TME, and which does not induce fratricidal killing of CAR-NK-92-cells. To evaluate this therapeutic approach, we harnessed intricate 3D multicellular tumor spheroid models (MCTS), which emulate key elements of the TME. Our results demonstrate the effective cytotoxicity of CEA-CAR-NK-92 cells against CRC in colorectal cell lines and MCTS models. Importantly, minimal off-target activity against non-cancerous cell lines underscores the precision of this therapy. Furthermore, the integration of the CCR4 migration receptor augments homing by recognizing target ligands, CCL17 and CCL22. Notably, our CAR design results in no significant trogocytosis-induced fratricide. In summary, the proposed CEA-targeting CAR-NK cell therapy could offer a promising solution for CRC treatment, combining precision and efficacy in a tailored approach. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.